Laufer, M.; Sarfaty, M.; Jacobi, E.; Itelman, E.; Segal, G.; Perelman, M.
Low Serum Alanine Aminotransferase Blood Activity Is Associated with Shortened Survival of Renal Cell Cancer Patients and Survivors: Retrospective Analysis of 1830 Patients. J. Clin. Med. 2024, 13, 5960.
https://doi.org/10.3390/jcm13195960
AMA Style
Laufer M, Sarfaty M, Jacobi E, Itelman E, Segal G, Perelman M.
Low Serum Alanine Aminotransferase Blood Activity Is Associated with Shortened Survival of Renal Cell Cancer Patients and Survivors: Retrospective Analysis of 1830 Patients. Journal of Clinical Medicine. 2024; 13(19):5960.
https://doi.org/10.3390/jcm13195960
Chicago/Turabian Style
Laufer, Menachem, Michal Sarfaty, Eyal Jacobi, Edward Itelman, Gad Segal, and Maxim Perelman.
2024. "Low Serum Alanine Aminotransferase Blood Activity Is Associated with Shortened Survival of Renal Cell Cancer Patients and Survivors: Retrospective Analysis of 1830 Patients" Journal of Clinical Medicine 13, no. 19: 5960.
https://doi.org/10.3390/jcm13195960
APA Style
Laufer, M., Sarfaty, M., Jacobi, E., Itelman, E., Segal, G., & Perelman, M.
(2024). Low Serum Alanine Aminotransferase Blood Activity Is Associated with Shortened Survival of Renal Cell Cancer Patients and Survivors: Retrospective Analysis of 1830 Patients. Journal of Clinical Medicine, 13(19), 5960.
https://doi.org/10.3390/jcm13195960
